Back to Search Start Over

MA15.07 Survival Benefit From Immunocheckpoint Inhibitors in Stage IV Non-small Cell Lung Cancer Patients ≥75 Years Old of Age

Authors :
Takefumi Komiya
Shinkichi Takamori
E. Powell
Source :
Journal of Thoracic Oncology. 16:S936
Publication Year :
2021
Publisher :
Elsevier BV, 2021.

Subjects

Subjects :
Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
Survival benefit
business.industry
Internal medicine
Medicine
business
Stage IV non-small cell lung cancer

Details

ISSN :
15560864
Volume :
16
Database :
OpenAIRE
Journal :
Journal of Thoracic Oncology
Accession number :
edsair.doi...........f4cb007cc9549e26e22f3d2a1a84068e
Full Text :
https://doi.org/10.1016/j.jtho.2021.08.193
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details